Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00826943 · ClinicalTrials.gov registry record · Phase 4
Is Levocetirizine Less Sedating Than Cetirizine?
A Phase 4 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00826943 is a Phase 4 study that has completed, run by Vanderbilt University. The registered enrollment target is 30 participants.
The verdict
NCT00826943, a Phase 4 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether cetirizine (zyrtec), levocetirizine (xyzal), and placebo differ in the degree of sedation they produce and their relief of allergy symptoms.
Interventions
- DRUG Placebo
- DRUG Cetirizine
- DRUG Levocetirizine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-05 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00826943
The ClinicalTrials.gov registry entry for NCT00826943 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00826943 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00826943 about?
NCT00826943 is a clinical study titled "Is Levocetirizine Less Sedating Than Cetirizine?". The purpose of this study is to determine whether cetirizine (zyrtec), levocetirizine (xyzal), and placebo differ in the degree of sedation they produce and their relief of allergy symptoms.
What is the current status of trial NCT00826943?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2009-01. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00826943?
The interventions under investigation include: Placebo (DRUG), Cetirizine (DRUG), Levocetirizine (DRUG).
Who is sponsoring clinical trial NCT00826943?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.